StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
This year
2
Publishing Date
2024 - 03 - 12
1
2024 - 01 - 30
1
2023 - 12 - 14
1
2022 - 03 - 02
1
2022 - 02 - 14
1
2022 - 01 - 31
1
2022 - 01 - 12
1
2022 - 01 - 05
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 11 - 18
1
2021 - 11 - 17
1
Sector
Communications
1
Health services
1
Health technology
12
Manufacturing
1
N/a
1
Technology services
1
Tags
Active
1
Adcetris
1
Antiviral
1
Breakthrough therapy
1
China
1
Clinical-trials-phase-iii
3
Collaboration
1
Covid
1
Covid-19
1
Designation
1
Earnings
1
Fda
1
Fda-approvals
1
Financial
1
Grant
1
Granted
1
Migraine
1
N/a
3
Order
1
People
2
Phase 2
1
Phase 2/3
1
Phase 3
1
Positive
2
Program
1
Research
2
Respiratory
1
Results
3
Risk
1
Therapy
1
Topline
2
Topline results
1
Treatment
2
Trial
2
Vaccine
2
Women
1
Entities
Arvinas, inc.
1
Astellas pharma inc
1
Biohaven pharmaceutical holding company ltd.
1
Biontech se
1
Epizyme, inc.
1
Genmab a/s
1
Humana inc.
1
Ionis pharmaceuticals, inc.
1
Medies
1
Orange
1
Pfizer, inc.
12
Sanofi
1
Transunion
1
Symbols
ABEO
11
ABT
9
AEM
15
AGFY
9
AMAT
9
AMYT
10
ARVL
48
ASTI
9
AVXL
10
AYRWF
12
BBIO
17
BCPC
9
BDX
11
BLIN
11
BMY
10
BRKR
11
CGC
11
CLAY
10
CNC
10
CPT
10
DHR
12
ENB
15
ERIC
28
F
11
FBIO
12
FCN
15
FIAC
12
FNCTF
99
GILT
13
HEPA
16
HON
11
HUBS
44
JNJ
61
LCLP
11
LILM
10
LLY
19
LTUM
12
LVO
13
MC
13
MRK
13
MRNA
10
MS
72
NGVC
10
NVO
10
OCGN
12
PFE
12
PPRUF
14
PPRUY
14
SNY
44
SNYNF
41
TAC
19
TGTX
11
THTX
10
TMO
13
VRCA
10
VSAC
15
WLDS
16
XELA
14
XYF
12
ZBH
10
Exchanges
Nasdaq
5
Nyse
12
Crawled Date
2024 - 03 - 12
1
2024 - 01 - 30
1
2023 - 12 - 14
1
2022 - 03 - 02
1
2022 - 02 - 14
1
2022 - 01 - 31
1
2022 - 01 - 12
1
2022 - 01 - 05
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 11 - 18
1
2021 - 11 - 17
1
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
38
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
www.biospace.com
9
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Pfe
crawled time :
12:30
save search
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Published:
2024-03-12
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-10.4%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
adcetris
positive
trial
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Published:
2024-01-30
(Crawled : 12:30)
- biospace.com/
GNMSF
|
$290.38
3.33%
3.83%
220
|
Health Technology
|
1.86%
|
O:
2.14%
H:
1.03%
C:
-0.89%
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-15.47%
|
O:
1.76%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-19.48%
|
O:
-3.53%
H:
3.49%
C:
3.4%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-7.5%
|
O:
1.49%
H:
1.72%
C:
-3.12%
GMAB
|
$28.33
-0.7%
-0.74%
220K
|
Health Technology
|
0.85%
|
O:
0.42%
H:
0.04%
C:
-0.99%
ARVN
|
$34.29
2.51%
2.48%
800K
|
Health Technology
|
-15.43%
|
O:
-0.46%
H:
0.79%
C:
0.28%
financial
results
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
Published:
2023-12-14
(Crawled : 12:30)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-4.65%
|
O:
0.38%
H:
2.07%
C:
-2.35%
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women
Published:
2022-03-02
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-45.57%
|
O:
-1.01%
H:
0.0%
C:
0.0%
fda
respiratory
granted
active
therapy
women
vaccine
breakthrough therapy
grant
designation
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Published:
2022-02-14
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-49.94%
|
O:
-1.89%
H:
1.36%
C:
-0.04%
BHVN
|
News
0 d
|
$42.16
-4.25%
0.1%
3.7M
|
Health Technology
|
-68.73%
|
O:
0.27%
H:
2.86%
C:
1.95%
treatment
trial
migraine
china
topline results
positive
results
topline
Pfizer and Ionis announce discontinuation of vupanorsen clinical development program
Published:
2022-01-31
(Crawled : 12:30)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-53.21%
|
O:
-0.61%
H:
0.26%
C:
-2.43%
IONS
|
$40.81
-0.24%
-0.25%
990K
|
Health Technology
|
28.82%
|
O:
-10.54%
H:
12.88%
C:
12.21%
program
Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released
Published:
2022-01-12
(Crawled : 12:30)
- biospace.com/
FNCTF
|
News
|
$11.0354
-0.83%
-20.84%
0
|
Communications
|
0.6%
|
O:
0.0%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-55.23%
|
O:
-0.77%
H:
1.46%
C:
0.55%
phase 3
topline
order
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Published:
2022-01-05
(Crawled : 12:30)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-5.92%
|
O:
3.68%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-54.77%
|
O:
-0.73%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-8.34%
|
O:
0.91%
H:
0.0%
C:
0.0%
BNTX
|
$86.17
-0.27%
-0.24%
520K
|
Health Technology
|
-62.83%
|
O:
-0.85%
H:
0.0%
C:
0.0%
collaboration
vaccine
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Published:
2021-12-14
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-52.61%
|
O:
1.99%
H:
0.0%
C:
0.0%
covid-19
treatment
phase 2
risk
phase 2/3
covid
antiviral
results
Pfizer to Acquire Arena Pharmaceuticals
Published:
2021-12-13
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-50.4%
|
O:
4.66%
H:
0.0%
C:
0.0%
Epizyme Announces Updates to Its Board of Directors
Published:
2021-11-18
(Crawled : 12:30)
- biospace.com/
TRU
|
News
|
$67.01
-3.76%
0.0%
2.6M
|
Technology Services
|
-42.28%
|
O:
0.88%
H:
1.46%
C:
0.52%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-49.09%
|
O:
2.34%
H:
1.19%
C:
0.61%
HUM
4
|
$324.83
0.42%
-0.26%
1.3M
|
Health Services
|
-27.21%
|
O:
-1.19%
H:
1.6%
C:
1.57%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-67.37%
|
O:
-7.66%
H:
0.96%
C:
-7.93%
Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio
Published:
2021-11-17
(Crawled : 12:30)
- biospace.com/
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-48.6%
|
O:
0.95%
H:
0.0%
C:
0.0%
Gainers vs Losers
59%
41%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.